Development and Validation of a Novel Microbiome-Based Biomarker of Post-antibiotic Dysbiosis and Subsequent Restoration.

Blount, Ken; Jones, Courtney; Walsh, Dana; Gonzalez, Carlos; Shannon, William D

Blount, Ken; Jones, Courtney; Walsh, Dana; Gonzalez, Carlos; Shannon, William D.

Afiliación

Blount K; Rebiotix Inc., a Ferring Company, Roseville, MN, United States.
Jones C; Rebiotix Inc., a Ferring Company, Roseville, MN, United States.
Walsh D; Rebiotix Inc., a Ferring Company, Roseville, MN, United States.
Gonzalez C; BioRankings LLC, St. Louis, MO, United States.
Shannon WD; BioRankings LLC, St. Louis, MO, United States.

Front Microbiol ; 12: 781275, 2021.

Article en En | MEDLINE | ID: mdl-35058900

Palabras clave

Clostridioides difficile infection; antibiotics; biomarker; dysbiosis; intestinal microbiota

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Microbiol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google